Lynn Seely
President and CEO at Lyell Immunopharma Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 2 boards, counting each seat separately. Longest: Lyell Immunopharma Inc., 2 years.
Lyell Immunopharma Inc.
Director · President and CEO
AbCellera Biologics Inc.
Director
Chief executive roles
Lyell Immunopharma Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Lyell Immunopharma Inc. | Open-market sale | −390 | $14.34 | $5,593 |
| May 11, 2026 | Lyell Immunopharma Inc. | Open-market sale | −388 | $18.91 | $7,337 |
| Feb 11, 2026 | Lyell Immunopharma Inc. | Open-market sale | −7,455 | $23.39 | $174,372 |
| Feb 10, 2026 | Lyell Immunopharma Inc. | Open-market sale | −438 | $23.12 | $10,127 |
| Feb 9, 2026 | Lyell Immunopharma Inc. | Grant or award | +20,000 | — | — |
| Nov 10, 2025 | Lyell Immunopharma Inc. | Open-market sale | −412 | $16.11 | $6,637 |
| Aug 21, 2025 | Lyell Immunopharma Inc. | Open-market sale | −7,257 | $10.54 | $76,489 |
| Aug 20, 2025 | Lyell Immunopharma Inc. | Grant or award | +40,000 | — | — |
| Aug 12, 2025 | Lyell Immunopharma Inc. | Open-market sale | −406 | $10.34 | $4,198 |
| Aug 11, 2025 | Lyell Immunopharma Inc. | Open-market sale | −391 | $10.53 | $4,117 |
| Mar 14, 2025 | Lyell Immunopharma Inc. | Open-market purchase | +175,000 | $0.61 | $106,750 |
| Feb 10, 2025 | Lyell Immunopharma Inc. | Grant or award | +337,500 | — | — |
| Feb 9, 2024 | Lyell Immunopharma Inc. | Grant or award | +200,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.